Results 201 to 210 of about 19,649 (222)

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

Lancet, The, 2002
Nikolas von Bubnoff
exaly  

Flying under the radar: the new wave of BCR–ABL inhibitors

Nature Reviews Drug Discovery, 2007
Hagop M Kantarjian, Jorge Cortes
exaly  

Regulation of the c-Abl and Bcr–Abl tyrosine kinases

Nature Reviews Molecular Cell Biology, 2004
Oliver D Hantschel, Giulio Superti-Furga
exaly  

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Nature Medicine, 1996
Brian J Druker
exaly  

Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia

Nature Reviews Cancer, 2005
Ruibao Ren
exaly  

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

Nature Reviews Cancer, 2007
Sandra W Cowan-Jacob, Andreas Hochhaus
exaly  

Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation

Cancer Cell, 2008
Hendrik Veelken, Katja Zirlik
exaly  

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Cancer Cell, 2005
Ellen L Weisberg, Paul W Manley, Sandra W Cowan-Jacob   +2 more
exaly  

BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner

Cell, 1991
Ann Marie Pendergast, Alexander J Muller, Owen N Witte   +2 more
exaly  

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

New England Journal of Medicine, 2001
Brian J Druker, Moshe Talpaz, Hagop M Kantarjian   +2 more
exaly